Radiotherapy devices are used to treat cancer patients by exposing the cancerous tissues to X-rays, gamma rays, and charged particles.

NE WIN SIVERS DRIVE, PROVINCE: - PORTLAND, UNITED STATES, September 23, 2021 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, Radiotherapy Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global radiotherapy market was valued at $4,723million in 2016, and is projected to reach at $7,222million by 2023, growing at a CAGR of 6.2% from 2017 to 2023. The external beam radiation therapy segment accounted for more than four-fifths of the total market in 2016.

Radiotherapy devices are used to treat cancer patients by exposing the cancerous tissues to X-rays, gamma rays, and charged particles. The market is driven by growth in number of cancer patients, increase in geriatric population, rise in adoption of radiotherapy devices and procedures, owing to surge in number of awareness campaigns about the benefits of radiotherapy, and technological advancements in radiotherapy devices. However, dearth of skilled personnel and difficulty in tumor visualization restrict the market growth. Furthermore, growth opportunities in emerging markets and increase in demand for cancer treatment are expected to provide numerous opportunities for market growth during the forecast period.

(A PDF | Sample Of The Report Is Available Immediately Upon Request)@ https://www.alliedmarketresearch.com/request-sample/2367

The external beam radiation therapy segment is expected to maintain its dominant position throughout the analysis period, due to rise in the demand for radiotherapy procedures and the increased incidence of different types of cancers. In addition, brachytherapy segment is expected to grow at a high CAGR of 9.9% from 2017 to 2023.

Key Findings of the Radiotherapy Market:
The external beam radiation therapy segment accounted for more than four-fifths of the total market in 2016.
The hospitals segment accounted for more than three-fifths of the total market in 2016.
Asia-Pacific is expected grow at the highest CAGR of 7.5% from 2017 to 2022
North America accounted for majority of the share (nearly two-fifths) in the market in 2016, and is expected to maintain its dominance throughout the forecast period, owing to increased adoption of radiotherapy devices, enhanced technological advancements, and development of novel products by the key players. In addition, rise in the elderly population, favorable reimbursement rates, prevalence of different types of cancers, and advanced healthcare infrastructure fuel the market growth.

Get Detailed COVID-19 Impact Analysis on the Radiotherapy Market @ https://www.alliedmarketresearch.com/request-for-customization/2367?reqfor=covid

The major companies profiled in the report include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, IBA (Ion Beam Applications SA), Nordion, Inc., C. R. Bard, Inc., Isoray Medical, Inc., Raysearch Laboratories AB, Mevion Medical Systems, Inc., and Mitsubishi Electric Corporation.

Similar Exclusive Reports:

Thrombectomy Devices Market:- https://www.alliedmarketresearch.com/thrombectomy-devices-market
Prefilled Syringes Market:- https://www.alliedmarketresearch.com/prefilled-syringes-market
Photomedicine Market:- https://www.alliedmarketresearch.com/photomedicine-market

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.